Vasculitis: Clinical Trials

12 trials for Vasculitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 completed. 12 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 412Completed 12

Follow Vasculitis: new trials by email Literature Review of Vasculitis trials Research Report on Vasculitis

Trials (filtered) newest first · largest first

All 12 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Six-months Versus Nine-months ATT for Ocular TB
Anti-Tuberculosis Treatment - Tuberculosis (TB), Uveitis
Phase 4CompletedL.V. Prasad Eye Institute582020-01-012024-09-26
Study of Combined Therapy IVIG-SN 10% and Acetylsalicylic Acid in Kawasaki Disease
Immunoglobulin G, Acetylsalicylic acid - Kawasaki Disease
Phase 4CompletedGreen Cross Corporation452019-02-012020-05-21
Tocilizumab Plus a Short Prednisone Taper for GCA
Tocilizumab, Prednisone - Giant Cell Arteritis
Phase 4CompletedMassachusetts General Hospital302018-11-282022-12-02
Saline vs. Lactated Ringers for Emergency Department IV Fluid Resuscitation
Lactated Ringer Solution, Normal Saline 0.9% Infusion Solution Bag - Fluid Loss, Symptom Complex, Triple
Phase 4CompletedNicholas M Mohr1572017-05-232018-09-11
Combined Pneumococcal Conjugate and Polysaccharide Vaccination in Inflammatory Rheumatic Disease
13-valent pneumococcal conjugate vaccine, 23-valent pneumococcal polysaccharide vaccine - Rheumatoid Arthritis, Systemic Lupus
Phase 4CompletedRegion Skane3002016-06-142023-03-29
A Study Evaluating the Safety and Efficacy of Rituximab in Combination With Glucocorticoids in Participants With Wegener's Granulomatosis or Microscopic Polyangitis
Methylprednisolone, Prednisone, Rituximab - Wegener's Granulomatosis or Microscopic Polyangiitis
Phase 4CompletedHoffmann-La Roche302015-07-062022-07-06
Pilot Study of Short-Course Glucocorticoids and Rituximab for Treatment of ANCA-Associated Vasculitis
Glucocorticoids, Rituximab - Granulomatosis With Polyangiitis, Microscopic Polyangiitis
Phase 4CompletedMassachusetts General Hospital202014-06-012021-06-25
Study of Combined Therapy of Aspirin and "IVIG-SN" in Kawasaki Disease
immunoglobulin G - Kawasaki Disease
Phase 4CompletedGreen Cross Corporation452012-01-012012-09-20
Efficacy of Low Molecular Weight Heparin in Superficial Vein Thrombosis
Dalteparin - Superficial Thrombophlebitis
Phase 4CompletedUniversity Medical Centre Ljubljana682010-12-012018-05-04
Treatment of Necrotizing Vasculitides for Patients Older Than 65 Years
prednisone, methylprednisolone,cyclophosphamides, Cyclophosphamide, Azathioprine,prednisone,methylprednisolone, Mycophenolate mofetil,methotrexate - Vasculitis, Wegener's Granulomatosis
Phase 4CompletedAssistance Publique - Hôpitaux de Paris1082005-07-012011-09-12
Management of Superficial Thrombophlebitis
Dalteparin sodium injection - Superficial Thrombophlebitis, Upper Extremity Superficial Thrombophlebitis
Phase 4CompletedUniversity of Oklahoma722002-10-012013-11-18
HSP-glomerulonephritis Trial: MP vs CyA
Methylprednisolone pulses plus prednisone versus Cyclosporine A - Purpura, Schoenlein-Henoch
Phase 4CompletedOulu University Hospital202000-01-012011-08-08

Narrower conditions

Granulomatosis with Polyangiitis (3)  ·  Microscopic Polyangiitis (3)  ·  Mucocutaneous Lymph Node Syndrome (2)  ·  Arthritis, Rheumatoid (1)  ·  Behcet Syndrome (1)  ·  Choroiditis (1)  ·  Churg-Strauss Syndrome (1)  ·  Emergencies (1)  ·  Giant Cell Arteritis (1)  ·  Glomerulonephritis (1)  ·  IgA Vasculitis (1)  ·  Nephritis (1)  ·  Nephrotic Syndrome (1)  ·  Phlebitis (1)  ·  Pneumococcal Infections (1)

Broader conditions

Cardiovascular Diseases (12)  ·  Vascular Diseases (12)  ·  Skin and Connective Tissue Diseases (9)  ·  Skin Diseases (8)  ·  Skin Diseases, Vascular (8)  ·  Immune System Diseases (6)  ·  Autoimmune Diseases (5)  ·  Brain Diseases (4)  ·  Central Nervous System Diseases (4)  ·  Cerebrovascular Disorders (4)  ·  Hemic and Lymphatic Diseases (4)  ·  Lung Diseases (4)  ·  Nervous System Diseases (4)  ·  Respiratory Tract Diseases (4)

Interventions

Prednisone (4)  ·  Dalteparin (2)  ·  Glucocorticoids (2)  ·  Immunoglobulin G (2)  ·  Methylprednisolone (2)  ·  Rituximab (2)  ·  13-valent pneumococcal vaccine (1)  ·  23-valent pneumococcal capsular polysaccharide vaccine (1)  ·  Aspirin (1)  ·  Azathioprine (1)  ·  Cyclophosphamide (1)  ·  Methotrexate (1)  ·  Mycophenolic Acid (1)  ·  Pneumococcal Vaccines (1)  ·  Ringer's Lactate (1)

Sponsors

Green Cross Corporation (2)  ·  Massachusetts General Hospital (2)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Hoffmann-La Roche (1)  ·  L.V. Prasad Eye Institute (1)  ·  Nicholas M Mohr (1)  ·  Oulu University Hospital (1)  ·  Region Skane (1)  ·  University Medical Centre Ljubljana (1)  ·  University of Oklahoma (1)

Countries

United States (4)  ·  India (2)  ·  South Korea (2)  ·  Burma (1)  ·  Finland (1)  ·  France (1)  ·  Slovenia (1)  ·  Thailand (1)

Top investigators

Ana D Fernandes, MA (1)  ·  Jehns Martineus, MD (1)  ·  John H Stone, MD (1)  ·  June Huh, MD,Ph.D (1)  ·  Matti Nuutinen, M.D., Ph.D. (1)  ·  Mi Young Han, MD, Ph.D. (1)  ·  Pavel Poredos, M.D., Ph.D. (1)  ·  Suman Rathbun, M.D. (1)

Results publications

PMID 21626222, PMID 22360152, PMID 24807875, PMID 25693055, PMID 30146446, PMID 32087733, PMID 36853224, PMID 38251564